Source: IMAGE

Cannabinoid hyperemesis syndrome is an unusual illness that is characterized by cyclic vomiting in individuals who use cannabis regularly over an extended period of time. This syndrome is rarely diagnosed in medical practice.

Cannabis is generally known to act as an antiemetic agent, making cannabinoid hyperemesis syndrome a true medical paradox. It is usually mistaken for cyclic vomiting syndrome, gastroparesis, or another digestive disease.

According to the original case series that first characterized the condition, CHS was formally described in Australia in 2004. Clinical recognition has lagged behind its actual prevalence as cannabis use has increased following broader legalization.

Why CHS Is So Often Missed

The diagnosis is delayed since CHS occurs among those who take cannabis to control nausea, making it less intuitive that there is any cause-and-effect relationship.

Several factors compound the diagnostic delay:

• Reporting bias: Patients tend not to report cannabis use to healthcare providers, particularly in emergencies, for fear of stigma or legal repercussions.
• Treatment paradox: Patients tend to consume more cannabis in the prodromal period, in the belief that it will alleviate nausea symptoms, which further aggravates the condition.
• Repeat testing: Conventional therapy for antiemetics proves to be futile, and hence, patients face numerous hospitalizations and tests until the cannabis abuse issue is raised.
• Low clinical awareness: CHS is a relatively new diagnosis, and many healthcare professionals lack training in recognizing particular symptoms of this syndrome.

Epidemiology and Risk Factors

CHS is linked with prolonged use of cannabis, where the use occurs frequently, that is, at least once per week for one or more years.

Risk appears to scale with both frequency and potency of use rather than any single dose threshold. Patterns identified across case series and cohort studies include:

• Onset typically in patients with a multi-year history of near-daily cannabis use
• Higher reported incidence with higher-potency cannabis products
• No strong association with a specific route of administration (smoking, vaping, and edibles have all been implicated)
• Increasing case reports coinciding with wider legal access and higher-potency product availability

Defining the Clinical Presentation

CHS usually has a combination of three symptoms, including vomiting attacks, hot bathing compulsion, and chronic marijuana use.

People with CHS normally manifest symptoms that make CHS distinguishable from other disorders and aid in diagnosis of the disease. One of these symptoms is a compulsion to have a hot shower or bath.

Presentations typically follow a phasic pattern:

• Prodromal phase: Morning sickness, mild abdominal distress, and fear of vomiting, which may continue for months to years prior to being diagnosed.
• Hyperemetic phase: Severe and cyclical vomiting to such an extent that one may end up visiting the emergency room several times, usually along with abdominal distress and ritual hot baths.
• Recovery phase: Complete relief of symptoms following days to weeks after stopping cannabis consumption.

The Hot Bathing Clue

Compulsive bathing with hot water is probably one of the most trustworthy behavioral symptoms that allow differentiating CHS from other etiologies of cyclic vomiting.

Such a symptom is so specific that it must lead physicians to take a cannabis history, regardless of whether it was disclosed spontaneously or not. Here are a couple of clinical observations:

• Patients often report showering multiple times per day, sometimes for hours at a time, during an episode.
• Relief is normally temporary, necessitating repeat bathing during the attack.
• This behavior is rarely present in other causes of cyclic vomiting, which makes it a useful differentiating question during history-taking.

Proposed Pathophysiology

The exact pathophysiology of CHS is currently unknown; however, present research focuses on abnormal signaling of the cannabinoid receptors in the gut-brain axis.

Cannabinoids exert dose-dependent and duration-dependent effects on the enteric and central nervous systems, which likely explains the paradox at the center of CHS. Acute, low-dose cannabinoid exposure is broadly antiemetic through CB1 receptor activity in the central nervous system, while chronic, high-dose exposure appears to produce the opposite effect through receptor downregulation and altered signaling within the autonomic pathways that help regulate visceral function.

Additional proposed mechanisms include:

• Accumulation of cannabinoid metabolites in the fat cells due to prolonged use
• Disruption of the hypothalamic-pituitary-adrenal axis, affecting thermoregulation and intestinal movement
• Different genetic mutations within the cannabinoid receptors of the patients
• Changes in the movements of the stomach due to prolonged exposure to cannabinoids

Differential Diagnosis Considerations

CHS is a diagnosis of exclusion, requiring clinicians to rule out other causes of cyclic vomiting before confirming the presentation.

Because CHS shares overlapping features with several other conditions, a thorough differential workup matters before settling on the diagnosis. This is especially relevant given how frequently patients presenting with unexplained nausea, vomiting, and abdominal pain receive extensive, and often unnecessary, diagnostic workups before a cannabis use history is adequately explored.

Conditions to rule out typically include:

• Cyclic vomiting syndrome (a related but distinct condition with a different symptom trigger pattern)
• Gastroparesis
• Peptic ulcer disease
• Biliary or pancreatic pathology
• Adrenal insufficiency
• Bowel obstruction, in patients with significant abdominal pain

A detailed cannabis use history, including frequency, duration, and potency of use, is often the single most useful diagnostic tool, yet it is also the most commonly overlooked step in the workup.

Diagnostic Criteria and Clinical Workup

Diagnosis involves both the taking of a medical history and the recognition of a characteristic symptom profile without the availability of a definitive test.

CHS lacks a lab or radiographic diagnostic test. Diagnosis is largely a clinical process involving:

• Documented history of long-term cannabis use, typically for a year or more, at high frequency
• Cyclic vomiting episodes consistent with the phasic pattern described above
• Symptomatic relief specifically with hot bathing
• Resolution of symptoms with sustained cannabis cessation

Routine evaluation includes basic metabolic profile, liver function tests, lipase levels, and imaging studies to rule out structural pathologies. Tests mentioned above are used more as exclusionary measures for the diagnosis of CHS as opposed to confirmation, since no test finding is diagnostic for the disease.

ICD-10 Coding and Documentation Notes

The accurate coding and proper documentation of the history of cannabis use are important for the purpose of treating the patients individually and from an epidemiologic point of view.

CHS is usually documented with the help of codes related to cannabis dependence or abuse together with a code for vomiting, as there isn’t a standard ICD-10 code for CHS. Some documentation points to keep in mind are:

• Record the frequency, duration, and strength of cannabis use when feasible
• Indicate presence and severity of hot bath-taking
• Document the patient’s reaction to cannabis discontinuation counseling, which may aid in diagnosing retrospectively

Management and Treatment Approaches

The cessation of cannabis use is the only known treatment, but supportive therapy may be considered in treating the symptoms during the hyperemetic stage.

In acute cases, conventional antiemetic medications like ondansetron are often ineffective, and this in itself is a red flag indicating a possible diagnosis of CHS. Capsaicin cream application on the abdomen has shown effectiveness in certain case reports because of its TRPV1 activation effect, like hot bath therapy.

Supportive management during acute episodes typically includes:

• IV fluids used to treat dehydration, considering the importance of this because of the severity of episodes of vomiting
• Benzodiazepines, which have shown better symptom response than standard antiemetics in several case series
• Topical capsaicin as an adjunct measure
• Counseling on cannabis cessation as the only measure shown to resolve the underlying condition long-term

Why Standard Antiemetics Often Fail

The relative ineffectiveness of first-line antiemetics in CHS is itself a useful diagnostic signal.

Ondansetron and other 5-HT3 antagonists act on the serotonergic system, which is not the major cause of CHS-related nausea. Several implications of this information include:

• Poor response to standard antiemetics should raise suspicion for CHS in patients with a compatible history
• Benzodiazepines seem to work better, probably because of their wider CNS effects.
• Capsaicin has been reported to help with some symptoms owing to the fact that it provides similar sensations to the heat provided by bathing.

Long-Term Outcomes and Patient Counseling

Symptom relief is possible, but only with persistent cannabis abstinence, and relapse is frequent when cannabis use is resumed.

Those individuals who are able to stop using cannabis usually experience complete relief from symptoms within a week or two. Yet, the symptoms of compulsion to bathe and the cyclical vomiting will soon repeat themselves if cannabis use is resumed.

Clinicians should approach counseling around cannabis cessation without judgment, since patients are often using cannabis specifically to manage nausea, unaware that it is the underlying cause. This paradox is increasingly relevant in regions with legal, high-frequency access, including areas served by providers such as weed delivery Roseville, where regular use has become more normalized and less likely to be volunteered during history-taking. A few counseling points worth emphasizing with patients:

• Reappearance of symptoms after resumption of drug intake is not unusual, nor does it indicate another medical problem.
• Relief from hot bathing, while real, is not a sustainable long-term management strategy.
• Complete cessation is generally necessary for full relief of symptoms.

Frequently Asked Questions

What is cannabinoid hyperemesis syndrome?
CHS is a condition seen in chronic, long-term cannabis users characterized by cyclic episodes of severe nausea and vomiting, often accompanied by compulsive hot bathing behavior.

According to the National Institutes of Health’s StatPearls clinical reference on Cannabinoid Hyperemesis Syndrome, the condition is frequently misdiagnosed due to its paradoxical presentation in patients who use cannabis partly for its antiemetic properties.

Why does hot bathing relieve symptoms in CHS?

Hot baths are believed to alleviate symptoms by way of TRPV1 receptor activation and hypothalamic thermoregulation, but the exact mechanism is yet to be established.

How is CHS different from cyclic vomiting syndrome?

CHS has been found to be caused by chronic marijuana abuse. CHS will improve after stopping marijuana intake. Unlike CHS, cyclic vomiting is unrelated to chronic cannabis usage.

Is there a specific test to diagnose CHS?

There is no single laboratory or radiological test that can be used to diagnose CHS. The diagnosis depends on the clinical history and the symptom pattern.

Can CHS be treated without stopping cannabis use?

While supportive treatments such as IV fluids, benzodiazepines, and capsaicin can address acute symptoms, complete resolution of symptoms is possible only if the patient is abstinent from cannabis use.

Conclusion

Cannabinoid hyperemesis syndrome remains underdiagnosed largely because its presentation runs counter to cannabis’s reputation as an antiemetic. Recognizing the clinical triad of cyclic vomiting, compulsive hot bathing, and a history of chronic cannabis use allows clinicians to reach the correct diagnosis faster, reduce unnecessary diagnostic workups, and counsel patients toward the only intervention shown to resolve the condition: cessation of use.

Stay updated, free articles. Join our Telegram channel

Join